Simultaneously, physiological modifications such as proline buildup, increased non-photochemical quenching, and alterations in gas exchange and photosynthetic parameters facilitate the preservation of photosystem II integrity and adaptability to stress
Patients should be counseled that experiencing some gastrointestinal discomfort is normal and does not indicate treatment failure or intolerance, provided symptoms remain manageable
They are consistent with the known side effect profile of GLP-1 receptor agonists already approved in the UK (see, for example, the Wegovy Summary of Product Characteristics, available via the electronic Medicines Compendium)
In the Stop-signal task, mean reaction time to correctly-responded Go trials within a testing visit, rate of correctly-inhibited Stop trials (i.e
The SURPASS-CVOT trial is specifically evaluating tirzepatide cardiovascular outcomes